[go: up one dir, main page]

AU7766391A - Thrombus-specific antibody derivatives - Google Patents

Thrombus-specific antibody derivatives

Info

Publication number
AU7766391A
AU7766391A AU77663/91A AU7766391A AU7766391A AU 7766391 A AU7766391 A AU 7766391A AU 77663/91 A AU77663/91 A AU 77663/91A AU 7766391 A AU7766391 A AU 7766391A AU 7766391 A AU7766391 A AU 7766391A
Authority
AU
Australia
Prior art keywords
thrombus
specific antibody
antibody derivatives
derivatives
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU77663/91A
Inventor
Marc De Maeyer
Paul Holvoet
Yves Laroche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corvas International Nv
Original Assignee
CORVAS INTERNATIONAL N V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CORVAS INTERNATIONAL N V filed Critical CORVAS INTERNATIONAL N V
Publication of AU7766391A publication Critical patent/AU7766391A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU77663/91A 1990-04-23 1991-04-21 Thrombus-specific antibody derivatives Abandoned AU7766391A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90401090 1990-04-23
EP90401090 1990-04-23

Publications (1)

Publication Number Publication Date
AU7766391A true AU7766391A (en) 1991-11-11

Family

ID=8205704

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77663/91A Abandoned AU7766391A (en) 1990-04-23 1991-04-21 Thrombus-specific antibody derivatives

Country Status (2)

Country Link
AU (1) AU7766391A (en)
WO (1) WO1991016353A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994009034A1 (en) * 1992-10-12 1994-04-28 Agen Limited Clot directed anticoagulant, process for making same and methods of use

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3720353B2 (en) * 1992-12-04 2005-11-24 メディカル リサーチ カウンシル Multivalent and multispecific binding proteins, their production and use
US5443827A (en) * 1993-05-03 1995-08-22 President And Fellows Of Harvard College Fibrin-targeted inhibitors of thrombin
US6303369B1 (en) * 1993-09-30 2001-10-16 Carl Spana Protein expression system
WO1997015601A1 (en) * 1995-10-20 1997-05-01 Novartis Ag Process for the preparation of a single chain fv antibody fragment
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
AU766551C (en) 1998-08-28 2005-02-17 Genentech Inc. Human anti-factor IX/IXa antibodies
AU3475100A (en) * 1999-01-29 2000-08-18 Imclone Systems Incorporated Antibodies specific to kdr and uses thereof
JP2003508027A (en) * 1999-07-29 2003-03-04 ダイアックス コーポレイション Fibrin binding moiety
US6984373B2 (en) 2000-12-23 2006-01-10 Dyax Corp. Fibrin binding moieties useful as imaging agents
US7972596B2 (en) 2004-11-18 2011-07-05 Imclone Llc Antibodies against vascular endothelial growth factor receptor-1
GB0425569D0 (en) * 2004-11-19 2004-12-22 Celltech R&D Ltd Biological products
RU2486204C2 (en) * 2005-07-22 2013-06-27 Уай'З Терапьютикс Ко., Лтд. Cd26 antibodies and methods of using them
MA34907B1 (en) 2011-01-14 2014-02-01 Ucb Pharma Sa ANTIBODY MOLECULES BINDING TO IL-17A AND IL-17F
EP3099719B1 (en) 2014-01-29 2020-04-01 Dana-Farber Cancer Institute, Inc. Antibodies against the muc1-c/extracellular domain (muc1-c/ecd)
US10617773B2 (en) 2016-08-05 2020-04-14 Dana-Farber Cancer Institute, Inc. Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339445C (en) * 1986-11-12 1997-09-09 The General Hospital Corporation Recombinant hybrid immunoglobulin molecules and method of use
JPH02504472A (en) * 1988-06-03 1990-12-20 セルテック　リミテッド hybrid protein

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994009034A1 (en) * 1992-10-12 1994-04-28 Agen Limited Clot directed anticoagulant, process for making same and methods of use

Also Published As

Publication number Publication date
WO1991016353A1 (en) 1991-10-31

Similar Documents

Publication Publication Date Title
AU653734B2 (en) Substituted 4-biphenylmethoxypyridine derivatives
AU639126B2 (en) Oxorapamycin
AU644249B2 (en) Alpha-oxoacetamide derivatives
AU7707591A (en) Hydroquinazoline derivatives
AU8791591A (en) Tnf-muteins
AU7500891A (en) Benzimidazolinone derivatives
AU7903694A (en) Assays
AU6860691A (en) Azaoxindole derivatives
AU8405691A (en) Novel tetrahydrobenzazole derivative
AU7846991A (en) Aminobenzodiazepines
AU7766391A (en) Thrombus-specific antibody derivatives
AU7825291A (en) Pyridinypiperazine derivatives
AU7804691A (en) N-pyridinesulfonyl-N-pyrimidinyl-or-triazinylureas
AU7956191A (en) Transportsystem
AU7726391A (en) Slitterscorer
AU6531090A (en) Swagable fitting
AU8138991A (en) Carboxymethylcyclopropane derivatives
AU8740291A (en) 3d-spectacles
AU7566691A (en) Compostor
AU7587991A (en) Electrodermatome
AU7949691A (en) 5-isothiazolamine derivatives
AU8984191A (en) Thiadiazinones
AU7862291A (en) Modified antibodies
AU7083491A (en) Pyrimidin-2-ylphenylhydroxylamine derivatives
AU7922191A (en) 2-acylamino-7-chlorobenzothiazoles